View Full Version : OCLS - Oculus Innovative Sciences
Oculus Innovative Sciences Inc designs, produces, and markets prescription and non-prescription products in over 20 countries. It provides products for wound management, nursing home & home healthcare, dermatology and wound & skin care for consumers.
[IMG]
Oculus Innovative Sciences Receives U.S. FDA Approval for Lasercyn for Use Following Laser Procedures, Microdermabrasions and Chemical Peels
GlobeNewswire "Press Releases"
PETALUMA, Calif., April 20, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), a specialty pharmaceutical company that develops and marketssolutions for the treatment of dermatological conditions and advanced tissue care, today announced it has received a new 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the companys new Microcyn-based Lasercyn Gel. Under the supervision of a healthcare professional, Lasercyn Gel is intended for the management of post-non-ablative laser therapy procedures, post-microdermabrasion therapy and following superficial chemical peels. Lasercyn may also be used to relieve itch and pain from minor skin irritations, lacerations, abrasions and minor burns.
New highs today from the opening gap 1.27 +36%
L2 showing some resistance here 1.27, but at the moment, up and above its wide open to 1.40
Powered by vBulletin® Version 4.2.2 Copyright © 2024 vBulletin Solutions, Inc. All rights reserved.